Your session is about to expire
← Back to Search
PINS Bundle for Infant Intubation Safety (OPTION SAFE Trial)
OPTION SAFE Trial Summary
This trial will test a tool to help make intubation safer in NICUs, with the goal of improving patient outcomes.
OPTION SAFE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.OPTION SAFE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had an endotracheal tube exchange.My infant needs a breathing tube in the NICU.
- Group 1: Pre-Intervention Phase
- Group 2: Post-intervention Phase
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new participants being accepted for this research endeavor?
"According to the clinicaltrials.gov data, this research project is currently open for recruitment and has been since April 1st 2023. It was last modified on April 21st of that same year."
Approximately how many participants are enrolled in this clinical research study?
"This medical study necessitates the enrolment of 3000 eligible participants, who may register at any one of a number of locations including University of Colorado - Denver in Denver and Yale-New Haven Hospital in New Haven."
Is this trial in process at a multitude of locations within the city?
"The research is being conducted at the University of Colorado - Denver in Denver, Yale-New Haven Hospital in New Haven and Dartmouth-Hitchcock Clinic in Lebanon as well as other centres across the country."
Share this study with friends
Copy Link
Messenger